Care Management Technologies Announces New Client: Alliance Behavioral Healthcare

Morrisville, NC, August 19, 2015 - Care Management Technologies (CMT), a data-driven population health analytics company that specializes in behavioral health, today announced its newest client, Alliance Behavioral Healthcare.  Alliance will employ CMT’s ProAct, the industry leading behavioral healthcare data analytics and decision-support tool, to improve its approach to managing the overall health of its members. Benefits to Alliance will range from identifying opportunities to proactively address the needs of individuals before they experience the potentially devastating effects of chronic health issues, to enhanced ability to monitor and evaluate provider practices and the impact of its care integration efforts.

“We selected CMT because we believe that we will be able to leverage their analytics expertise and the knowledge base of their health care experts to accelerate the delivery and effectiveness of care integration for our members,” said Sean Schreiber, Chief Clinical Officer at Alliance.

“We’re excited to be working with Alliance Behavioral Healthcare,” said Carol Clayton, CEO at CMT.  “Our focus is on helping customers like Alliance who manage complex behavioral health populations, so they can improve quality of care and lower costs for their population.  With ProAct we can bring insight and action to comprehensive data sets, and enable clients to speed the implementation of best practices – optimizing care and reducing variability that leads to poor outcomes and high costs.”

Alliance will utilize ProAct’s capacity to combine clinical and claims data to gain a clear, 360° view of patient care and patient needs.  The company will also take advantage of ProAct’s more advanced features, including analyzing patients against an anonymized claims database with more than 800 million Medicaid, Medicare and private insurance claims data points, tracking performance improvements based on customized and industry metrics, providing action based analytics through interoperable platforms at the patient level, and utilizing CMT’s risk alerts to prevent emergency room and hospital readmissions.  In addition, Alliance will rely on groundbreaking work by CMT’s health experts which ensures that the latest evidence-based behavioral health research outcomes are incorporated directly into the analysis engine.

Using ProAct, Alliance can organize and analyze all available data to better understand and manage risk, taking into account everything from adherence markers and gaps in care to costly co-morbid conditions and underlying addiction or substance dependency concerns.  Drawing on more than 200 proprietary and validated clinical rules, ProAct will guide enhancements in Alliance decision-making that foster more efficient and effective delivery and management of care.

About Alliance Behavioral Healthcare
Alliance is one of North Carolina’s largest public behavioral health managed care organizations, or MCOs, operating under Medicaid 1915 (b)/(c) waivers.  It is responsible for the authorization of services for over 200,000 Medicaid-eligible individuals and a population of 1.7 million in Durham, Wake, Cumberland and Johnston counties.  The company’s stated vision is to be a leader in transforming the delivery of whole person care in the public sector.  Employing a staff in excess of 400, Alliance is headquartered near RTP and operates community-based offices in Durham, Raleigh, Fayetteville and Smithfield.

About Care Management Technologies
Care Management Technologies (CMT) has broad expertise and extensive experience in both behavioral health and advanced technologies.  CMT works with forward-thinking payer and provider organizations to address the opportunities and challenges presented by multimorbidity health populations: managing risk, and ensuring efficiency in clinical services and operations. In addition to creating proprietary health information technology, CMT has developed an extensive array of evidence-based rules that promote improvements in care, both behaviorally and medically.  CMT works with payers and providers across the US and Canada serving over 220 agencies touching 19 million consumer lives.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.